Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation;Estrés oxidativo de las lipoproteínas y efecto antioxidante de la vitamina C un año después de iniciar hemodiálisis

Nefrologia

Volumn 25, Issue 2, 2005, Pages 178-184

  Ramos, R ^a   Gomez Gerique N ^a   Martínez Castelao, Alberto M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Antioxidants; Haemodialysis; LDL oxidation; Oxidative stress; Vitamin C

Indexed keywords

ASCORBIC ACID; LIPOPROTEIN; VITAMIN;

ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ASCORBIC ACID; ATHEROSCLEROSIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; LIPOPROTEINS; MALE; MIDDLE AGED; RENAL DIALYSIS; VITAMINS;

EID: 33644816954     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Loughrey CM, Young IS, McEneny J, McDowell FW, McMaster C, McNamee P, Trimble ER: Oxidation of low-density lipoprotein in patients on regular haemodialysis. Atherosclerosis 110: 185-193, 1994.
2. Raine AEG, MacMahon SH, Selwood NH, Wing AJ and Brunner FP: Mortality from myocardical infarction in patients on renal replacement therapy. Nephrol Dial Transplant 6: 902, 1991.
3. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knech Weissgarten Y, Brunner D, Fainaru M, Green MS: Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomised placebo controlled trial. Lancet 356: 1213-1218, 2000.
4. Tepel M, Van der Giet M, Statz M, Jankowski J, Zidek W: The antioxidant Acetyl cysteine reduces cardiovascular events in patients with end stage renal disease. Circulation 107: 992, 2003.
5. Shulz TH, Schiffl H, Scheithe R, Hrboticky N and Lorenz R. Preserved antioxidative defence of lipoproteins in renal failure and during hemodialysis. Am J Kidney Dis XXV(4): 564-571, 1995.
6. Himmelfarb J, Stenvinkel P, Alp Ikizler T, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney International 62: 1524-1538, 2002 .
7. Wratten ML,Tetta C, Ursini F, Sevanian A. Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int 58 (Supl. 76): S126-S132, 2000.
8. Toborek M, Wasik T, Drózdz M, Klin M, Magner-Wróbel, Kopieczna-Grzebieinak E: Effect of Hemodialysis on Lipid Peroxidation and Antioxidant System in Patients with Chronic Renal Failure. Metabolism 41(11): 1229-1232, 1992.
9. Heimann P, Josephson MA, Fellner SK, Thiestlethwaite JR, Stuart FP, Dasgupta A: Elevated lipoprotein (a) levels in renal transplantation and hemodialysis patients. Am J Kidney Dis 11: 470-474, 1991.
10. Sakurai T, Oka T, Hasegawa H, Igaki N, Miki S, Goto: Comparison of lipids, apoproteins ad associated enzyme activities between diabetic and nondiabetic end-stage renal disease. Nephron 61: 409-414, 1992.
11. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamin A, E, and iron status. Free Rad Biol Med 16:339, 1994.
12. Maher ER, Wickens DG, Griffin JF, Kyle P, Curtis JR, Dormandy Tl: Increased free-radical activity during haemodialysis? Nephrol Dial Transplant 2: 169-171, 1987.
13. Fillit H, Elion E, Sullivan J, Sherman R, Zabriskie J: Thiobarbituric acid reactive material in uremic blood. Nephron 29: 40-43, 1981.
14. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, Cordonnier D: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57: 10-15, 1991.
15. Dasgupta A, Hussain S, Ahmad S: Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 60: 56-59, 1992.
16. Wen Y, Cooke T, Feely J: The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation. Br J Clin Pharmacol 44: 94-97, 1997.
17. Halliwell B: Vitamin C: Antioxidant or pro-oxidant in vivo? Free Rad Res 25: 439-454, 1996.
18. Buettner GR: The pecking order of free radicals and antioxidants: lipid peroxidation, alpha tocopherol, and ascorbate. Arch Biochem Biophys 300(2): 535-43, 1993.
19. Sacarpa M, Rigo A, Maiorino M, Ursini F, Gregolin C: Formation of alpha-tocopherol radical and recycling of alpha-tocopherol by ascorbate during peroxidation of phosphatidylcoline liposomes. An electron paramagnetic resonsance study. Biochim Biophys Acta 801(2): 215-219, 1984.
20. May JM: Is ascorbic acid an antioxidant for the plasma membrane? FASEB J 13(9): 995-1006, 1999.